Therefore, to minimize this effect, in youth with type 2 diabetes, metformin and long‐ or intermediate‐acting insulin were discontinued 48 h prior to the clamp, as has been reported previously [13, 14]. The gene discussed is INS; the disease is type 2 diabetes mellitus.